The Idiopathic Pulmonary Fibrosis (IPF) Treatment Market is gaining significant traction as the prevalence of chronic respiratory disorders continues to rise worldwide. IPF is a rare, progressive lung disease characterized by scarring of lung tissues, which leads to irreversible loss of respiratory function. While its exact cause remains unknown, growing awareness, advances in...